S. Miri Et Al. , "Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results," ISTH 2023 , Montreal, Canada, pp.1, 2023
Miri, S. Et Al. 2023. Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results. ISTH 2023 , (Montreal, Canada), 1.
Miri, S., Rosendaal, F., Kavaklı, K., Eshghi, P., Moghaddam, S. M., Elalfy, M., ... Halimeh, S.(2023). Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results . ISTH 2023 (pp.1). Montreal, Canada
Miri, Syna Et Al. "Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results," ISTH 2023, Montreal, Canada, 2023
Miri, Syna Et Al. "Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results." ISTH 2023 , Montreal, Canada, pp.1, 2023
Miri, S. Et Al. (2023) . "Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results." ISTH 2023 , Montreal, Canada, p.1.
@conferencepaper{conferencepaper, author={Syna Miri Et Al. }, title={Inhibitor development upon switch after 50 EDs from plasma derived to recombinant FVIII in PUPs with severe hemophilia A: the PUP SWITCH study results}, congress name={ISTH 2023}, city={Montreal}, country={Canada}, year={2023}, pages={1} }